Diane Blake to Cost-Benefit Analysis
This is a "connection" page, showing publications Diane Blake has written about Cost-Benefit Analysis.
Connection Strength
0.384
-
Blake DR, Spielberg F, Levy V, Lensing S, Wolff PA, Venkatasubramanian L, Acevedo N, Padian N, Chattopadhyay I, Gaydos CA. Could home sexually transmitted infection specimen collection with e-prescription be a cost-effective strategy for clinical trials and clinical care? Sex Transm Dis. 2015 Jan; 42(1):13-9.
Score: 0.104
-
Huang W, Gaydos CA, Barnes MR, Jett-Goheen M, Blake DR. Cost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection. Sex Transm Dis. 2011 Sep; 38(9):815-20.
Score: 0.083
-
Blake DR, Maldeis N, Barnes MR, Hardick A, Quinn TC, Gaydos CA. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis. 2008 Jul; 35(7):649-55.
Score: 0.066
-
Blake DR, Quinn TC, Gaydos CA. Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program. Sex Transm Dis. 2008 Jan; 35(1):91-101.
Score: 0.064
-
Blake DR, Gaydos CA, Quinn TC. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention. Sex Transm Dis. 2004 Feb; 31(2):85-95.
Score: 0.049
-
Gift TL, Blake DR, Gaydos CA, Marrazzo JM. The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature. Sex Transm Dis. 2008 Nov; 35(11 Suppl):S51-60.
Score: 0.017